09/16/2026
Had breast cancer? You may have been told estrogen is off the table — forever.
The 2025 AUA/SUFU/AUGS guideline says the answer is more nuanced.
Local low-dose vaginal estrogen may be recommended for women with a personal history of breast cancer through multidisciplinary shared decision-making. It isn’t the same as systemic estrogen — systemic absorption from low-dose vaginal preparations is generally low.
And the safety data are reassuring: in a large observational study of 49,237 women with breast cancer, vaginal estrogen use was not linked to an increase in breast-cancer-specific mortality. Observational data can’t prove zero risk — but this is real, published evidence.
It’s still not a “yes for everyone.” Your decision may depend on your cancer type, hormone-receptor status, current treatment, whether you’re on tamoxifen vs. an aromatase inhibitor, and how much your symptoms are affecting your life.
If dryness, burning, pain with s*x, urinary symptoms, or recurrent UTIs are wearing you down, that’s a conversation worth having — not something to quietly live with.
Ask your team: “Is low-dose vaginal estrogen appropriate for me?”
Swipe through, then save this and send it to someone who needs it.
Source: Kaufman MR, Ackerman LA, Amin KA, et al. The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. The Journal of Urology. 2025;214(3):242–250.
🔗 iconichealthmed.com
💌 [email protected]
☁️ 954.571.9392
📍 1898 W Hillsboro Blvd, Deerfield Beach, FL